| Medical and Health Sciences | Lifetime | 755 | US 388 | 99.97 |
| Medical and Health Sciences | 2021-2025 | 35 | US 17 | 99.99 |
| Dermatology | Lifetime | 9 | US 5 | 99.91 |
| Immunology and Allergy | Lifetime | 24 | US 15 | 99.58 |
| Medical Physiology | Lifetime | 532 | US 283 | 99.10 |
| Rheumatology | Lifetime | 889 | US 409 | 94.87 |
| Cell Biology | Lifetime | 987 | US 529 | 92.93 |
| Dermatology | 2021-2025 | 1 | US 1 | 99.98 |
| Immunology and Allergy | 2021-2025 | 1 | US 1 | 99.96 |
| Medical Physiology | 2021-2025 | 35 | US 19 | 99.56 |
| Rheumatology | 2021-2025 | 210 | US 61 | 94.15 |
| Immunology | 2021-2025 | 424 | US 157 | 88.17 |
| Cell Biology | 2021-2025 | 262 | US 103 | 69.59 |
| Pathology and Forensic Medicine | 2021-2025 | 547 | US 172 | 69.27 |
| Allergic Rhinitis and Sensitization | Lifetime | 17 | US 8 | 99.87 |
| Dermatology and Skin Diseases | Lifetime | 17 | US 10 | 99.83 |
| Food Allergy and Anaphylaxis Research | Lifetime | 17 | US 9 | 99.79 |
| Contact Dermatitis and Allergies | Lifetime | 21 | US 8 | 99.61 |
| Asthma and respiratory diseases | Lifetime | 90 | US 36 | 99.72 |
| Urticaria and Related Conditions | Lifetime | 35 | US 16 | 99.44 |
| melanin and skin pigmentation | Lifetime | 133 | US 60 | 98.32 |
| Complementary and Alternative Medicine Studies | Lifetime | 98 | US 44 | 98.20 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 163 | US 69 | 98.20 |
| Autoimmune Bullous Skin Diseases | Lifetime | 191 | US 68 | 98.43 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 222 | US 74 | 98.19 |
| Mast cells and histamine | Lifetime | 314 | US 122 | 96.63 |
| Drug-Induced Adverse Reactions | Lifetime | 366 | US 115 | 95.28 |
| Acne and Rosacea Treatments and Effects | Lifetime | 249 | US 107 | 95.09 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 97 | US 32 | 94.40 |
| Nail Diseases and Treatments | Lifetime | 839 | US 321 | 94.27 |
| IL-33, ST2, and ILC Pathways | Lifetime | 780 | US 303 | 93.41 |
| Occupational exposure and asthma | Lifetime | 525 | US 161 | 92.88 |
| Medicine and Dermatology Studies History | Lifetime | 810 | US 297 | 81.45 |
| Dermatology and Skin Diseases | 2021-2025 | 1 | US 1 | 99.96 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 1 | US 1 | 99.97 |
| Asthma and respiratory diseases | 2021-2025 | 2 | US 1 | 99.92 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 1 | US 1 | 99.93 |
| Contact Dermatitis and Allergies | 2021-2025 | 1 | US 1 | 99.89 |
| Urticaria and Related Conditions | 2021-2025 | 8 | US 5 | 99.49 |
| Occupational exposure and asthma | 2021-2025 | 4 | US 1 | 97.73 |
| Complementary and Alternative Medicine Studies | 2021-2025 | 9 | US 2 | 97.95 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 84 | US 6 | 95.22 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 79 | US 30 | 94.54 |
| Transgenic Plants and Applications | 2021-2025 | 68 | US 15 | 89.66 |
| Pesticide Exposure and Toxicity | 2021-2025 | 133 | US 25 | 88.95 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 386 | US 66 | 88.50 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 535 | US 90 | 88.61 |
| Health and Medical Studies | 2021-2025 | 200 | US 2 | 81.94 |
| Adrenal Hormones and Disorders | 2021-2025 | 337 | US 50 | 81.83 |
| Pharmaceutical studies and practices | 2021-2025 | 652 | US 205 | 79.39 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 241 | US 69 | 77.81 |
| Exercise and Physiological Responses | 2021-2025 | 851 | US 138 | 76.00 |
| Immunotoxicology and immune responses | 2021-2025 | 60 | US 19 | 73.79 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 880 | US 196 | 72.08 |
| Skin Protection and Aging | 2021-2025 | 997 | US 165 | 71.45 |
| Nail Diseases and Treatments | 2021-2025 | 913 | US 185 | 69.52 |
| Mast cells and histamine | 2021-2025 | 728 | US 156 | 66.66 |
| Medicine and Dermatology Studies History | 2021-2025 | 193 | US 101 | 60.61 |
| Herbal Medicine Research Studies | 2021-2025 | 480 | US 26 | 34.78 |
